Abstract
The effect of omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels was studied in 12 healthy volunteers. Omeprazole, 40 mg enteric-coated granules, or placebo was given once daily for nine days in a double-blind crossover study design. Twenty-four hours after a single dose of omeprazole, mean basal and mean pentagastrin-stimulated acid output decreased significantly. This effect was more pronounced after nine days of treatment. Basal pepsin output was significantly reduced only in those subjects with basal anacidity during omeprazole treatment. Stimulated pepsin output was slightly reduced after a single dose but unaltered after nine days of omeprazole. Fasting serum gastrin and serum pepsinogen I levels increased significantly during omeprazole treatment. It is concluded that omeprazole is a potent and selective inhibitor of gastric acid secretion, probably without a direct effect on pepsin secretion. However, in cases of basal anacidity during omeprazole administration, basal pepsin secretion is reduced. During omeprazole treatment, fasting serum levels of gastrin and pepsinogen I rise.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L: Effect of omeprazole, a gastric proton pump inhibitor, on pentagastrin stimulated acid secretion in man. Gut 24:270–276, 1983
Larsson H, Carlsson E, Junggren U, Olbe L, Sjöstrand SE, Skånberg I, Sundell G: Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology 85:900–907, 1983
Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjöstra SE, Wallmark B: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+-K+)-ATPase. Nature 290:159–161, 1981
Binder HJ, Donaldson RM: Effect of cimetidine on intrinsic factor and pepsin secretion in man. Gastroenterology 74: 371–375, 1978
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS: Ranitidine: A review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24:267–303, 1982
Mohammed R, Holden RJ, Hearns JB, McKibben BM, Buchanan KD, Crean GP: Effect of eight weeks continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion and fasting serum gastrin. Gut 24:61–66, 1983
Brogden RN, Heel RC, Speight TM, Avery GS: Cimetidine: A review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs 15:93–131, 1978
Sheers R, Roberts NB: The effects of pirenzepine and ranitidine on pepsin secretion.In Proceedings of a Symposium on Advances in Gastroenterology with the Selective Antimuscarinic Compound Pirenzepine. G Dotevall (ed). Amsterdam, Excerpta Medica, pp 83–87, 1981
Konturek SJ, Kweicien N, Obtulowicz W, Kopp B, Oleksy J: Action of omeprazole (a benzimidazole derivate) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients. Gut 25:14–18, 1984
Wilson JA, Boyd EJS, Wormsley KG: Effect of intraduodenal omeprazole on gastric acid and pepsin secretion. Gut 24:A497–498, 1983
Kittang E, Aadland E, Schjønsby H: Effect of omeprazole on acid, pepsin and intrinsic factor (IF) secretion in healthy subjects. Scand J Gastroenterol 19(Suppl 98): 2, 1984
Fryklund J, Wallmark B, Larsson H, Helander H: Effect of omeprazole on gastric secretion in H+, K+-ATPase and in pepsinogen rich cell fractions from rabbit gastric mucosa. Biochem Pharmacol 33:273–280, 1984
Peters MN, Feldman M, Walsh JH, Richardson CT: Effect of gastric alkalinization on serum gastrin levels in humans. Gastroenterology 85:35–39, 1983
Berstad A: A modified hemoglobin substrate method for the estimation of pepsin in gastric juice. Scand J Gastroenterol 5:343–348, 1970
Lamers C: Some aspects of the Zollinger-Ellison syndrome and serum gastrin. PhD thesis, Nijmegen, 1976
Biemond I, Pals G, Gilians J, Kreuning J, Pena AS: Enzymelinked immunosorbent assay of pepsinogen I.In Pepsinogens in Man: Clinical and Genetic Advances. J Kreuning, I Samloff, J Rotter, A Eriksson (eds). New York, Alan R. Liss, 1985, pp 55–66
Londong W, Londong V, Cederberg C, Steffen H: Dose-response study of omeprazole on meal-stimulated acid secretion and serum gastrin. Gastroenterology 85:1373–1378, 1983
Bynum TE, Johnson LR: Stimulation of human pepsin output by topical hydrochloric acid. Am J Dig Dis 20:607–612, 1975
Kapadia CR, Donaldson RM: Macromolecular secretion by isolated gastric mucosa. Gastroenterology 74:535–539, 1978
Johnson LR: Effect of gastric mucosal acidification on the action of pepsinogens. Am J Physiol 225:1411–1415, 1973
Festen HPM, Thijs JC, Lamers CBHW, Jansen JMBJ, Pals G, Frants RR, Défize J, Meuwissen SGM: The effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 87:1030–1034, 1984
Bins M, Borgers PICJ, Selbach SGM, Wettum ThB van, Lamers CBHW, Tongeren JHM van: The relation between basal gastric pH and serum gastrin. Digestion 23:271–273, 1982
Gedde-Dahl D: Fasting serum gastrin levels in humans with low pentagastrin-stimulated gastric acid secretion. Scand J Gastroenterol 9:597–599, 1974
Author information
Authors and Affiliations
Additional information
Omeprazole was supplied by A. B. Hässle, Mölndal, Sweden.
Rights and permissions
About this article
Cite this article
Festen, H.P.M., Tuynman, H.A.R.E., Défize, J. et al. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Digest Dis Sci 31, 561–566 (1986). https://doi.org/10.1007/BF01318685
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01318685